Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia in Brazil mostly affects postmenopausal women, often linked with hypothyroidism and eyebrow hair loss.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

NKG2D gene polymorphism doesn't affect SLE risk but may influence symptoms like rash and hair loss.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The document explains various skin conditions and their treatments.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Certain drugs can cause lupus, stopping these drugs is the main treatment. NB-UVB phototherapy clears psoriasis faster when applied three times a week. Monoclonal antibodies and oral pimecrolimus are effective in treating psoriasis. Smoking and drinking are linked to psoriasis in men. No direct link between low iron and hair loss was found. Vaccines are effective against genital herpes and human papillomavirus type 16.

Yale-New Haven Hospital won a top award for greatly improving asthma care and reducing related hospital visits and costs.

The book is a valuable reference on androgenic disorders for professionals but not suitable for laypeople or medical students.

Taking calcium may help elderly with osteoporosis, birth control with levonorgestrel doesn't increase heart attack risk, Salmonella can cause arthritis, a national ethics committee is recommended, and sulfasalazine might help with a hair loss condition.

Semecarpus anacardium Linn. is a plant with many health benefits, including reducing inflammation, fighting cancer, and stimulating hair growth.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

More research is needed to understand alopecia areata severity.

Researchers created LabeledIn, a detailed list of drug uses, showing the importance of human input in making such lists.

Chinese patients with systemic lupus erythematosus commonly experience oral ulcers, arthritis, alopecia, skin rash, and nephritis.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Microbes might play a role in vitiligo.

A drug helped quickly reduce a movement disorder, experts debated the severity of Raynaud phenomenon, and rapid weight loss was linked to temporary hair loss with good recovery.

Stress can worsen skin and hair conditions by affecting the skin's immune response and hormone levels.

Toxic Shock Syndrome mainly affects menstruating women, can recur, and is linked to staph bacteria, with rapid treatment being crucial.

The EFSUMB created basic guidelines for using ultrasound in skin-related medical practice.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

COVID-19 doesn't make alopecia areata worse.

Hydroxychloroquine helped improve scleromyxoedema in patients, but caused side effects in some.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

Personality traits significantly affect the onset, progression, and psychological impact of alopecia areata.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.